POMALIDOMIDE | A210236 | HETERO LABS LTD UNIT V
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2019-02-14 | Terminated 2020-10-28 | — | |
| D.N.J. | 2018-09-20 | Terminated 2019-02-07 | — | |
CELGENE CORPORATION v. HETERO LABS LIMITED et al 4 patentsANDA 210236, 210249, 210164, 210275, 210111pomalidomide | D.N.J. | 2017-05-11 | Terminated 2021-08-19 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.